Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00342212 · ClinicalTrials.gov registry record

Actigraph Accelerometer Validation Study

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status

NCT00342212: Completed study, sponsored by National Cancer Institute (NCI).

NCT00342212 is a clinical trial that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00342212 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status

Study Summary

Background: * Good measures of physical activity are needed for studies correlating physical activity and the risk of developing certain diseases. * In preparation for use in a study of diseases and risk factors in Hispanic populations, NCI is evaluating a new model accelerometer to measure physical activity. An accelerometer is a small device worn on a belt at the waist that measures and records movement, capturing movement intensity and duration and associating it with clock-time. * The new accelerometer (ActiGraph GTIM) uses a different type of motion detector from that used in the previous model (ActiGraph 7164). Objective: To evaluate and compare the ActiGraph GTIM with the ActiGraph 7164 by collecting physical activity data using both models. Eligibility: Men and women 18-74 years of age. Design: Study participants wear both model accelerometers while they walk or jog around a track at several self-selected paces. Data from the two devices are compared.

Trial Details

FieldValue
Start Date 2006-03
Est. Completion 2008-04
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00342212 record still lists

NCT00342212 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 0 interventions.

NCT00342212 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00342212 about?

NCT00342212 is a clinical study titled "Actigraph Accelerometer Validation Study". Background: * Good measures of physical activity are needed for studies correlating physical activity and the risk of developing certain diseases. * In preparation for use in a study of diseases and risk factors in Hispanic populations, NCI is evaluating a new model accelerometer to measure physica...

What is the current status of trial NCT00342212?

This trial is currently completed. The study started on 2006-03. Estimated completion is 2008-04.

Who is sponsoring clinical trial NCT00342212?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00342212, the US trial registry maintained by the National Library of Medicine. NCT00342212 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.